Perrigo (PRGO) Work In Process (2023 - 2026)

Perrigo (PRGO) posted quarterly Work In Process of $35.7 million for Q1 2026, down 4.29% quarter-over-quarter from $37.3 million in Q4 2025.

Perrigo (PRGO) Work In Process (2023 - 2026) Analysis & Trends

Perrigo (PRGO) has reported Work In Process for 4 consecutive years, with $35.7 million the latest figure, recorded in Q1 2026.

In Q1 2026, Work In Process changed N/A year-over-year to $35.7 million; the TTM figure through Mar 2026 stood at $35.7 million (changed N/A YoY), while the FY2025 annual figure was $37.3 million, down 15.03% from the prior year.
Work In Process declined to $35.7 million in Q1 2026 per PRGO's latest filing, from $37.3 million in the prior quarter.
Across five years, Work In Process topped out at $43.9 million in Q4 2024 and bottomed at $28.5 million in Q4 2023.
Historically, Work In Process has averaged $36.4 million across 4 years, with a median of $36.5 million in 2025.
Annual changes were most pronounced in 2024 — Work In Process surged 54.04% — and 2025, when it slipped 15.03%.
Perrigo's Work In Process stood at $28.5 million in 2023, then soared by 54.04% to $43.9 million in 2024, then decreased by 15.03% to $37.3 million in 2025, then fell by 4.29% to $35.7 million in 2026.
Business Quant data shows PRGO's Work In Process at $35.7 million in Q1 2026, $37.3 million in Q4 2025, and $43.9 million in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	44.07 Bn	43.10 Bn	-
2	Teva Pharmaceutical Industries	43.42 Bn	39.76 Bn	2.15 Bn
3	Zoetis	31.86 Bn	30.18 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.77 Bn	22.98 Bn	5.10 Bn
5	United Therapeutics	22.29 Bn	19.63 Bn	683.80 Mn
6	Viatris	18.78 Bn	17.89 Bn	1.46 Bn
7	Neurocrine Biosciences	15.66 Bn	15.27 Bn	935.80 Mn
8	Elanco Animal Health	11.91 Bn	11.38 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.16 Bn	10.00 Bn	-
10	Perrigo	1.91 Bn	1.51 Bn	313.90 Mn

Download Data